Header Logo

Connection

MUHAMMAD SOHAIL to Defibrillators, Implantable

Back to Details
This is a "connection" page, showing publications MUHAMMAD SOHAIL has written about Defibrillators, Implantable.
MUHAMMAD SOHAIL
Connection Strength
13.626
Defibrillators, Implantable
  1. Discriminative Ability and Reliability of Transesophageal Echocardiography in Characterizing Cases of Cardiac Device Lead Vegetations Versus Noninfectious Echodensities. Clin Infect Dis. 2021 06 01; 72(11):1938-1943.
    View in: PubMed
    Score: 0.620
  2. Staphylococcus simulans bloodstream infection following CIED extraction. BMJ Case Rep. 2021 May 27; 14(5).
    View in: PubMed
    Score: 0.619
  3. Clinical Presentation, Timing, and Microbiology of CIED Infections: An Analysis of the WRAP-IT Trial. JACC Clin Electrophysiol. 2021 01; 7(1):50-61.
    View in: PubMed
    Score: 0.595
  4. Clinical Presentation, Management, and Outcomes of Cardiovascular Implantable Electronic Device Infections Due to Gram-Negative Versus Gram-Positive Bacteria. Mayo Clin Proc. 2019 07; 94(7):1268-1277.
    View in: PubMed
    Score: 0.532
  5. Interventions to Prevent CIED Infections: More or Less? J Am Coll Cardiol. 2018 12 18; 72(24):3110-3111.
    View in: PubMed
    Score: 0.523
  6. Infection Management. Card Electrophysiol Clin. 2018 12; 10(4):601-607.
    View in: PubMed
    Score: 0.521
  7. Approach to Diagnosis of Cardiovascular Implantable-Electronic-Device Infection. J Clin Microbiol. 2018 07; 56(7).
    View in: PubMed
    Score: 0.506
  8. Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection. Pacing Clin Electrophysiol. 2018 05; 41(5):495-503.
    View in: PubMed
    Score: 0.497
  9. International survey of knowledge, attitudes, and practices of cardiologists regarding prevention and management of cardiac implantable electronic device infections. Pacing Clin Electrophysiol. 2017 Nov; 40(11):1260-1268.
    View in: PubMed
    Score: 0.480
  10. Role of 18F-FDG PET/CT in the diagnosis of cardiovascular implantable electronic device infections: A meta-analysis. J Nucl Cardiol. 2019 06; 26(3):958-970.
    View in: PubMed
    Score: 0.479
  11. Strategies to prevent infections associated with cardiovascular implantable electronic devices. Expert Rev Med Devices. 2017 May; 14(5):371-381.
    View in: PubMed
    Score: 0.467
  12. Management of bacteremia in patients living with cardiovascular implantable electronic devices. Heart Rhythm. 2016 11; 13(11):2247-2252.
    View in: PubMed
    Score: 0.445
  13. Incidence, Treatment Intensity, and Incremental Annual Expenditures for Patients Experiencing a Cardiac Implantable Electronic Device Infection: Evidence From a Large US Payer Database 1-Year Post Implantation. Circ Arrhythm Electrophysiol. 2016 08; 9(8).
    View in: PubMed
    Score: 0.443
  14. Usefulness of sonication of cardiovascular implantable electronic devices to enhance microbial detection. Am J Cardiol. 2015 Apr 01; 115(7):912-7.
    View in: PubMed
    Score: 0.398
  15. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol. 2015 Feb; 8(1):137-44.
    View in: PubMed
    Score: 0.396
  16. In reply to 'impact of ESRD on infections of implantable cardiac rhythm devices'. Am J Kidney Dis. 2015 Jan; 65(1):169-70.
    View in: PubMed
    Score: 0.393
  17. Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis?patients. Am J Kidney Dis. 2014 Jul; 64(1):104-10.
    View in: PubMed
    Score: 0.371
  18. Cardiovascular implantable electronic device infections in left ventricular assist device recipients. Pacing Clin Electrophysiol. 2014 Feb; 37(2):225-30.
    View in: PubMed
    Score: 0.362
  19. Comparison of mortality in women versus men with infections involving cardiovascular implantable electronic device. Am J Cardiol. 2013 Nov 01; 112(9):1403-9.
    View in: PubMed
    Score: 0.361
  20. Microbiology and pathogenesis of cardiovascular implantable electronic device infections. Circ Arrhythm Electrophysiol. 2012 Apr; 5(2):433-41.
    View in: PubMed
    Score: 0.328
  21. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011 Nov 14; 171(20):1821-8.
    View in: PubMed
    Score: 0.316
  22. Cardiovascular implantable electronic device infection: a stepwise approach to diagnosis and management. Cleve Clin J Med. 2011 Aug; 78(8):529-37.
    View in: PubMed
    Score: 0.313
  23. Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol. 2011 Aug; 31(2):171-83.
    View in: PubMed
    Score: 0.304
  24. Contemporary management of cardiovascular implantable electronic device infections. Expert Rev Anti Infect Ther. 2010 Jul; 8(7):831-9.
    View in: PubMed
    Score: 0.291
  25. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008 Jan; 83(1):46-53.
    View in: PubMed
    Score: 0.245
  26. Management of infected pacemakers and implantable cardioverter-defibrillators. Intern Med J. 2007 Jul; 37(7):509-10; author reply 510.
    View in: PubMed
    Score: 0.236
  27. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007 May 08; 49(18):1851-9.
    View in: PubMed
    Score: 0.233
  28. Resource utilization associated with hospital and office-based insertion of a miniaturized insertable cardiac monitor: results from the RIO 2 randomized US study. J Med Econ. 2020 Jul; 23(7):706-713.
    View in: PubMed
    Score: 0.144
  29. Cardiovascular implantable electronic device infections due to enterococcal species: Clinical features, management, and outcomes. Pacing Clin Electrophysiol. 2019 10; 42(10):1331-1339.
    View in: PubMed
    Score: 0.137
  30. Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A?Population-Based Study. JACC Clin Electrophysiol. 2019 09; 5(9):1071-1080.
    View in: PubMed
    Score: 0.137
  31. Attempted salvage of infected cardiovascular implantable electronic devices: Are there clinical factors that predict success? Pacing Clin Electrophysiol. 2018 05; 41(5):524-531.
    View in: PubMed
    Score: 0.124
  32. Impact of Abandoned Leads on Cardiovascular Implantable Electronic?Device Infections: A?Propensity Matched Analysis of MEDIC (Multicenter?Electrophysiologic Device Infection?Cohort). JACC Clin Electrophysiol. 2018 02; 4(2):201-208.
    View in: PubMed
    Score: 0.121
  33. Impacts of a care process model and inpatient electrophysiology service on cardiovascular implantable electronic device infections: a preliminary evaluation. J Interv Card Electrophysiol. 2017 Oct; 50(1):117-124.
    View in: PubMed
    Score: 0.119
  34. Antibacterial Envelope Is Associated With?Low Infection Rates After Implantable Cardioverter-Defibrillator and?Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies. JACC Clin Electrophysiol. 2017 10; 3(10):1158-1167.
    View in: PubMed
    Score: 0.117
  35. Reimplantation and Repeat Infection After Cardiac-Implantable Electronic Device Infections: Experience From the MEDIC (Multicenter Electrophysiologic Device Infection Cohort) Database. Circ Arrhythm Electrophysiol. 2017 Mar; 10(3).
    View in: PubMed
    Score: 0.115
  36. Cardiovascular Implantable Electronic Device Infections due to Propionibacterium Species. Pacing Clin Electrophysiol. 2016 Jun; 39(6):522-30.
    View in: PubMed
    Score: 0.109
  37. Role of PET Imaging in Management of Implantable Electronic Device Infection. JACC Cardiovasc Imaging. 2016 Mar; 9(3):291-3.
    View in: PubMed
    Score: 0.107
  38. Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry. JACC Cardiovasc Imaging. 2014 Jun; 7(6):541-9.
    View in: PubMed
    Score: 0.095
  39. Variability in clinical features of early versus late cardiovascular implantable electronic device pocket infections. Pacing Clin Electrophysiol. 2014 Aug; 37(8):955-62.
    View in: PubMed
    Score: 0.094
  40. Predictors of mortality in patients with cardiovascular implantable electronic device infections. Am J Cardiol. 2013 Mar 15; 111(6):874-9.
    View in: PubMed
    Score: 0.086
  41. Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections. Europace. 2013 Feb; 15(2):227-35.
    View in: PubMed
    Score: 0.085
  42. Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species. Am J Cardiol. 2012 Oct 15; 110(8):1143-9.
    View in: PubMed
    Score: 0.084
  43. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol. 2012 Feb 14; 59(7):681-7.
    View in: PubMed
    Score: 0.081
  44. Cardiac device-related endocarditis complicated by spinal abscess. Pacing Clin Electrophysiol. 2012 Mar; 35(3):269-74.
    View in: PubMed
    Score: 0.080
  45. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011 Nov; 8(11):1678-85.
    View in: PubMed
    Score: 0.077
  46. Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol. 2011 Apr; 34(4):450-9.
    View in: PubMed
    Score: 0.075
  47. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope. Pacing Clin Electrophysiol. 2011 Feb; 34(2):133-42.
    View in: PubMed
    Score: 0.074
  48. Outcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by Gram-positive cocci other than Staphylococcus aureus. Circ Arrhythm Electrophysiol. 2010 Dec; 3(6):639-45.
    View in: PubMed
    Score: 0.074
  49. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia. Pacing Clin Electrophysiol. 2010 Apr; 33(4):407-13.
    View in: PubMed
    Score: 0.069
  50. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007 Apr 09; 167(7):669-75.
    View in: PubMed
    Score: 0.058
  51. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with gram-negative bacteremia. Clin Infect Dis. 2006 Sep 15; 43(6):731-6.
    View in: PubMed
    Score: 0.055
  52. Contemporary management of cardiac implantable electronic device infection. Heart. 2019 06; 105(12):961-965.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.